Our commitment to accessibility

Mammologix is committed to ensuring that our website is accessible and usable for all visitors, including people with disabilities. We are actively working toward conformance with the Web Content Accessibility Guidelines (WCAG) 2.2 Level AA and use WCAG 2.2 AA as our internal accessibility target for public website content, reusable templates, forms, and interactive features. Accessibility is an ongoing process, and we continue to evaluate, test, and improve the website over time.

Conformance status

Mammologix.com partially conforms to WCAG 2.2 Level AA. “Partially conforms” means that some parts of the content may not yet fully meet all applicable success criteria. We are working to improve conformance through source-code remediation, content review, automated testing, manual testing, and ongoing quality assurance.

WCAG conformance applies to full web pages and, where applicable, complete user processes. Accordingly, we continue to evaluate both individual pages and key website interactions.

Pages evaluated

The following pages were audited on April 26, 2026, using axe DevTools Pro 4.11.1 (axe-core 4.11.1) and Lighthouse 13.0.2 (emulated desktop, Chromium 147). All pages returned a Lighthouse Accessibility score of 100 and zero automated axe violations under WCAG 2.1 AA.

• mammologix.com/ (Homepage)
• mammologix.com/services
• mammologix.com/pricing
• mammologix.com/about
• mammologix.com/contact
• mammologix.com/accessibility

Testing methodology

Our accessibility testing includes automated scans and manual review. Automated tools help identify potential accessibility issues efficiently, but they do not detect every accessibility barrier and are not a substitute for human review. W3C explains that accessibility evaluation tools can assist with testing, but they cannot check all accessibility aspects automatically, may produce false or misleading results, and cannot determine accessibility by themselves.

Our manual review may include keyboard navigation, focus visibility, heading structure, link purpose, form labels, error messaging, browser zoom, reduced-motion behavior, screen-reader compatibility, and review of complete user interactions.

Complete user journeys

We review key user journeys, not only individual pages. This includes pathways such as learning about our services, navigating between major sections, contacting our team, requesting information, and accessing linked resources.

WCAG 2.2 states that when a web page is part of a multi-step process, all pages in that process must conform at the specified level for the process to conform.

Accessibility target

We are pursuing WCAG 2.2 Level AA conformance across all public pages, shared templates, reusable components, forms, and interactive features on mammologix.com.

Our accessibility approach

Mammologix approaches accessibility as an ongoing quality, usability, and compliance effort. Our goal is not to rely on a single tool, plugin, widget, overlay, or automated scan. Instead, we work to improve accessibility through source-code remediation, reusable component review, automated testing, manual testing, user feedback, and ongoing monitoring.

We prioritize accessibility in the areas that most directly affect a visitor’s ability to understand our services, contact our team, request information, navigate the website, and complete essential website interactions.

Measures we are taking

• Semantic HTML with proper heading hierarchy and landmark regions
• Keyboard navigation support for all interactive controls
• Visible focus indicators on all interactive elements
• Meaningful alternative text for informative images
• Accessible form labels, error messages, and required field indicators
• Sufficient color contrast for text and interactive elements (minimum 4.5:1 for normal text, 3:1 for large text)
• Reduced motion support for users who prefer minimal animation
• Skip navigation link for keyboard users

Source-code and component remediation

We prioritize remediation at the template and component level so improvements apply consistently across the website. This includes review of shared navigation, headers, footers, buttons, links, forms, focus states, page templates, content modules, and interactive features.

Where accessibility improvements are identified, we work to address the underlying website code and content rather than relying solely on user-side adjustments.

Supplemental personalization tools

Mammologix may provide accessibility or personalization tools that allow visitors to adjust certain display or usability preferences. These tools are intended to supplement our broader accessibility efforts.

They are not treated as a replacement for WCAG-based remediation of the website’s underlying code, structure, content, forms, documents, or interactive features. A personalization tool may assist some users, but it does not by itself guarantee WCAG or ADA compliance.

Mammologix does not rely solely on any accessibility widget, overlay, plugin, or automated testing tool to establish accessibility. We use these tools, where appropriate, as part of a broader accessibility program that includes source-code remediation, reusable component review, automated testing, manual testing, user feedback, and ongoing monitoring. Our goal is to improve the accessibility of the underlying website itself, including templates, navigation, forms, content, documents, and key user interactions.

Any accessibility-related tool, widget, script, plugin, or third-party feature used on the website should not interfere with screen readers, keyboard navigation, browser zoom, visible focus, user stylesheets, or other assistive technologies. WCAG’s non-interference requirement provides that technologies used in a non-conforming way must not block users from accessing the rest of the page.

Known limitations

Lighthouse Best Practices scores across all pages are 92/100. The deduction is attributable to the CookieYes GDPR consent management platform, which sets a first-party analytics cookie (tpclickid) required for its compliance logging. This is inherent to the consent management system and cannot be removed without replacing the GDPR compliance tool.

Third-party content and linked services

Some parts of the website may link to or rely on third-party platforms, embedded tools, or external services. We seek to select vendors and third-party tools that support accessibility, but some third-party content or functionality may be outside our direct control.

Where we identify an accessibility issue involving third-party content, we will make a good-faith effort to contact the provider, identify an accessible alternative where practical, or assist users through another available communication channel.

Client login and external systems

The accessibility review described on this page applies to the public Mammologix website pages listed above. The Client Login and other external or password-protected systems may operate on separate platforms, domains, or technical environments and may be evaluated separately.

If you experience an accessibility barrier while using a client portal or external Mammologix-related system, please contact us so we can review the issue and assist you.

Report a barrier

If you encounter an accessibility barrier or have difficulty using any part of this website, please contact us. We take accessibility feedback seriously and will work to resolve issues promptly.

Email: accessibility@mammologix.com

You can also reach us through our contact page.

Accessibility feedback response

When an accessibility concern is reported, we will review the issue, attempt to reproduce the barrier, determine whether remediation or an accessible alternative is appropriate, and take reasonable steps to address the issue.

To help us respond effectively, please include the page URL, a description of the issue, the device and browser you are using, and any assistive technology involved, if you are comfortable sharing that information.

Ongoing commitment

Accessibility is an ongoing effort. We run automated axe and Lighthouse audits on a monthly basis across all public pages, and conduct manual keyboard and screen reader review before major releases. All future releases follow an accessibility quality assurance checklist before deployment.

Good-faith accessibility governance

Mammologix maintains accessibility as part of our website quality assurance process. Our ongoing efforts may include periodic automated scans, manual review, remediation tracking, release review, staff or vendor coordination, and review of user feedback.

Because websites, browsers, assistive technologies, third-party tools, and accessibility standards continue to evolve, accessibility is an ongoing effort rather than a one-time certification.

Last updated: 2026-05-06 · Version 2